A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2007
12/26/2007	EP1870400A1 Salts and crystalline salt forms of an 2-indolinone derivative
12/26/2007	EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors
12/26/2007	EP1870108A1 Antitumor agent and novel dnase
12/26/2007	EP1870095A1 Composition for increasing anti-oxidation activity in blood
12/26/2007	EP1870091A1 Liposome composition for induction of immunity
12/26/2007	EP1870089A1 A gynecological pharmaceutics-containing microspherical vascular suppository of sodium alginate and its preparation method
12/26/2007	EP1869185A1 Conjugate comprising p21 protein for the treatment of cancer
12/26/2007	EP1869086A1 Methods and compositions for modulating and detecting wisp activity
12/26/2007	EP1869047A1 Purine derivatives as receptor-tyrosine kinase activityinhibitors
12/26/2007	EP1869040A1 Dna-pk inhibitors
12/26/2007	EP1869036A1 Substituted 1,5-naphthyridine azolidinones as cdk inhibitors
12/26/2007	EP1869032A1 Pyrimidine derivatives for use as anticancer agents
12/26/2007	EP1869028A1 Pyrimidines as igf-i inhibitors
12/26/2007	EP1869027A2 Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
12/26/2007	EP1869022A1 Naphthalamide derivatives having antiproliferative activity
12/26/2007	EP1869021A1 Dna-pk inhibitors
12/26/2007	EP1869020A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl
12/26/2007	EP1869016A1 Imidazolo-5-yl-2-anilo-pyrimidines as agents for the inhibition of cell proliferation
12/26/2007	EP1869008A1 Inhibitors of prolyl endopeptidase
12/26/2007	EP1868997A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
12/26/2007	EP1868994A1 Sulfonylpyrroles as histone deacetylase inhibitors
12/26/2007	EP1868685A2 11ß-HYDROXYSTEROID DEHYDROGENASES
12/26/2007	EP1868649A2 Elimination of heterogeneous or mixed cell population in tumors
12/26/2007	EP1868648A2 Methods and compositions for modulating hyperstabilized c-met
12/26/2007	EP1868646A2 Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent
12/26/2007	EP1868644A1 Therapy of prostate cancer with ctla4 antibodies and hormonal therapy
12/26/2007	EP1868636A2 Uses of recombinant super-compound interferons
12/26/2007	EP1868633A2 Compositions and methods for the inhibition of dishevelled proteins
12/26/2007	EP1868619A1 Use of macrolides for treating intestinal inflammation
12/26/2007	EP1868615A2 Modulation of telomere length in telomerase positive cells and cancer therapy
12/26/2007	EP1868612A2 Novel compounds
12/26/2007	EP1868609A2 Prokineticin 1 receptor
12/26/2007	EP1868608A2 Method for administration of capecitabine
12/26/2007	EP1868604A2 Regulation of protein synthesis by inhibition of eif4e-eif4g interaction
12/26/2007	EP1868601A1 Mitotic kinesin inhibitors
12/26/2007	EP1868599A1 Antitumor combination comprising substituted acryloyl distamycin derivatives and antibodies inhibiting growth factors or their receptors
12/26/2007	EP1868579A1 Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
12/26/2007	EP1761536B1 Novel 2-benzylaminodihydropteridinones, method for producing them and use thereof as drugs
12/26/2007	EP1689717B1 Substituted isoquinolines useful in the treatment of diseases such as cancer and atherosclerosis
12/26/2007	EP1622624B1 Medicinal compositions comprising n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide and further cytostatics
12/26/2007	EP1539750B1 Pyrazolopyridines as cyclin dependent kinase inhibitors
12/26/2007	EP1503797B1 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
12/26/2007	EP1441714B1 Combinations comprising a selective cyclooxygenase-2 inhibitor
12/26/2007	EP1402894B1 Cancerous metastasis inhibitors containing carbacyclic phosphatidic acid derivatives
12/26/2007	EP1401869B1 Molecules and methods for inhibiting shedding of kim-1
12/26/2007	EP1333810B1 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
12/26/2007	EP1265914B1 Wnt-1 related polypeptides, and nucleic acids encoding the same
12/26/2007	EP1261363B1 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS
12/26/2007	EP1235596B1 Use of lytic toxins and toxin conjugates
12/26/2007	EP1233769B1 Imidazole derivatives
12/26/2007	EP1187634B1 Cell growth inhibition
12/26/2007	EP0996710B1 Component of bromelain
12/26/2007	EP0837630B1 Prodrugs of pharmaceuticals with improved bioavailability
12/26/2007	EP0778848B1 Agents for inducing apoptosis and applications of said agents in therapy
12/26/2007	EP0517829B2 Improved chimeric toxins
12/26/2007	CN101094857A Cytotoxic agents comprising new taxanes
12/26/2007	CN101094853A Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
12/26/2007	CN101094844A Chroman derivatives, medicaments and use in therapy
12/26/2007	CN101094839A Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives
12/26/2007	CN101094673A Combination comprising zd6474 and an antiandrogen
12/26/2007	CN101092636A Selectively replicating viral vectors
12/26/2007	CN101092635A pUCpGs plasmid with immunity activation, preparation method and application
12/26/2007	CN101092621A Uncoupling protein gene of lamprey and application
12/26/2007	CN101092457A Human source Fab antibody for anti recombined alkalescent fibroblast growth factor and application
12/26/2007	CN101092455A Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
12/26/2007	CN101092453A Therapeutic compounds comprised of anti-fc receptor binding agents
12/26/2007	CN101092452A Preparation method for both of micromolecule polypeptide of tumor chalone for anti angiogenesis, and fusion protein
12/26/2007	CN101092450A Heparinase polypeptide epitope combined to molecules in human MIIC ¿CI category
12/26/2007	CN101092441A Method for synthesizing nelarabine
12/26/2007	CN101092433A Cis [( trans 1R, 2R 1,2 cyclohexane diamine) .(beta ¿C phenyl isosuccinic acid radical) platinum (ó�)] complexes, and usage as anticancer medicine
12/26/2007	CN101092431A Derivative of organic phosphorus of containing structure of spirocyclic / cyclopropane, preparation method and application
12/26/2007	CN101092420A (1Z, 4Z, 5Z) ¿C 6 N isopropyl ¿C 6 - aza ¿C2 ¿C oxo ¿C 3 - oxa ¿C 4 ¿C methoxy ¿C dicyclo [3, 1, 0] hexane and preparation method
12/26/2007	CN101092419A (1Z, 4Z, 5Z) ¿C 6 N alkyl ¿C 6 ¿C aza ¿C2 ¿C oxo ¿C 3 ¿C oxa ¿C 4 ¿C methoxy ¿C dicyclo [3, 1, 0] hexane and preparation method
12/26/2007	CN101092417A Folacin analogue, and salt of folacin analogue in use for medical treatment
12/26/2007	CN101092416A Derivative of folacin alkylation and application
12/26/2007	CN101092408A Lactone compound of sweetsop connected through amido bond, synthetic method and application
12/26/2007	CN101092363A Compound of lignan in aryl tetrahydronaphthalene, preparartion method and application
12/26/2007	CN101091799A Medicine in use for treating gastric cancer, and preparation method
12/26/2007	CN101091798A Application of meaning inversed miRNA-210
12/26/2007	CN101091795A Prevention and treatment of synucleinopathic disease
12/26/2007	CN101091794A Composition in use for preventing and treating metastatic tumor
12/26/2007	CN101091784A Compound oral taking preparation of cantharis, and preparation method
12/26/2007	CN101091773A Preparation of Chinese traditional medicine for treating esophagus cancer
12/26/2007	CN101091769A Medicine for treating and preventing esophagus cancer and gastric cancer, and preparation method
12/26/2007	CN101091736A Composition of Chinese traditional medicine for treating tumor, and preparation method
12/26/2007	CN101091726A Composition of health care composed of Cordyceps militaris and unsaturated oligosaccharide aldehydic acid
12/26/2007	CN101091714A Liposome of precursor containing ginsenoside Rh2, and preparation method
12/26/2007	CN101091707A Medicinal usage of kuhseng extractive
12/26/2007	CN101091705A Application of compounds in isorhodanic ester classes for treating diseases of prostate and skin cancer
12/26/2007	CN101091698A New type antineoplastic medicine, and preparation method
12/26/2007	CN101091696A Self microemulsion preparation of Rubescensin A, and preparation method
12/26/2007	CN100357436C SiRNA for inhibiting Stat3 gene expression and preparation thereof
12/26/2007	CN100357320C ZIBC gene and its coded protein and uses
12/26/2007	CN100357311C 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
12/26/2007	CN100357308C Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
12/26/2007	CN100357295C Macrocyclic pyrimidines, their production and use as pharmaceutical agents
12/26/2007	CN100357293C Diazinopyrimidines
12/26/2007	CN100357287C Antineoplastic cocoa extracts and methods for making and using the same
12/26/2007	CN100357283C Methionyl aminopeptidase inhibitor
12/26/2007	CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors

1 ... 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 ... 2211